Options Update: Developmental companies' volatility elevated into data

Posted Jan 28th 2009 9:15AM by Paul Foster
Filed under: Options

Intermune (NASDAQ: ITMN) closed at $11.72. ITMN's Pirfenidone Capacity data is expected soon. ITMN February 12.5 straddle is priced at $7.40, April 12.5 straddle is at $9.80 and July 12.5 straddle is priced at $14.10 according to Track Data, suggesting large price movement.

Sequenom (NASDAQ: SQNM) closed at $23.09. SQNM will present Down's syndrome data after the market close today. SQNM February option implied volatility is at140; March is at 120; above its 26-week average of 103, according to Track Data, suggesting larger price movement.

Geron (NASDAQ: GERN), a biopharmaceutical company, closed at $7.24. On January 23, 2009 GERN received FDA clearance to begin a clinical tail of CRNOPC1 for patients with acute spinal cord injury. GERN over all option implied volatility of 95 is near its 26-week average according to Track Data, suggesting non-directional price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Tags: gern, Geron, Intermune, itmn, option implied volatility, OptionImpliedVolatility, Sequenom, sqnm